Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis

References

• SchreibmanLIntensive behavioral/psychoeducational treatments for autism: research needs and future directionsJ Autism Dev Disord200030537337811098871
   PubMed Web of Science ®Google Scholar
• OspinaMBKrebs SeidaJClarkBBehavioural and developmental interventions for autism spectrum disorder: a clinical systematic reviewPLoS One2008311e375519015734
   PubMed Web of Science ®Google Scholar
• SpreckleyMBoydREfficacy of applied behavioral intervention in preschool children with autism for improving cognitive, language, and adaptive behavior: a systematic review and meta-analysisJ Pediatr2009154333834418950798
   PubMed Web of Science ®Google Scholar
• MasiADeMayoMMGlozierNGuastellaAJAn Overview of Autism Spectrum Disorder, Heterogeneity and Treatment OptionsNeurosci Bull201733218319328213805
   PubMed Web of Science ®Google Scholar
• BéhérecLQuiliciGRosierAGerardinPCampionDGuillinOPharmacological treatments in patients with pervasive developmental disorders: A reviewEncephale201440218819624369879
   PubMed Web of Science ®Google Scholar
• AndersonLTCampbellMGregaDMPerryRSmallAMGreenWHHaloperidol in the treatment of infantile autism: effects on learning and behavioral symptomsAm J Psychiatry198414110119512026385731
   PubMed Web of Science ®Google Scholar
• AndersonLTCampbellMAdamsPSmallAMPerryRShellJThe effects of haloperidol on discrimination learning and behavioral symptoms in autistic childrenJ Autism Dev Disord19891922272392663834
   PubMed Web of Science ®Google Scholar
• MccrackenJTMcGoughJShahBRisperidone in children with autism and serious behavioral problemsN Engl J Med2002347531432112151468
   PubMed Web of Science ®Google Scholar
• MarcusRNOwenRKamenLA placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorderJ Am Acad Child Adolesc Psychiatry200948111110111919797985
   PubMed Web of Science ®Google Scholar
• CampbellMAndersonLTSmallAMPerryRGreenWHCaplanRThe effects of haloperidol on learning and behavior in autistic childrenJ Autism Dev Disord19821221671757174605
   PubMed Web of Science ®Google Scholar
• SheaSTurgayACarrollARisperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disordersPediatrics20041145e634e64115492353
   PubMed Web of Science ®Google Scholar
• TroostPWLahuisBESteenhuisMPLong-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation studyJ Am Acad Child Adolesc Psychiatry200544111137114416239862
   PubMed Web of Science ®Google Scholar
• NagarajRSinghiPMalhiPRisperidone in children with autism: randomized, placebo-controlled, double-blind studyJ Child Neurol200621645045516948927
   PubMed Web of Science ®Google Scholar
• El-SayehHGMorgantiCAripiprazole for schizophreniaCochrane Database Syst Rev20042CD004578
   Google Scholar
• LiDJTsengPTStubbsBEfficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trialsProg Neuropsychopharmacol Biol Psychiatry201779Pt B28930128651936
   PubMed Web of Science ®Google Scholar
• OwenRSikichLMarcusRNAripiprazole in the treatment of irritability in children and adolescents with autistic disorderPediatrics200912461533154019948625
   PubMed Web of Science ®Google Scholar
• IchikawaHMikamiKOkadaTAripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled StudyChild Psychiatry Hum Dev201748579680628004215
   PubMed Web of Science ®Google Scholar
• HigginsJPTAltmanDGSterneJACon behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods GroupAssessing risk of bias in included studiesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration2011
   Google Scholar
• AmanMGSinghNNStewartAWFieldCJThe aberrant behavior checklist: a behavior rating scale for the assessment of treatment effectsAm J Ment Defic19858954854913993694
   PubMedGoogle Scholar
• AmanMGSinghNNStewartAWFieldCJPsychometric characteristics of the aberrant behavior checklistAm J Ment Defic19858954925023158201
   PubMedGoogle Scholar
• CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisLancet2009373966574675819185342
   PubMed Web of Science ®Google Scholar
• PapakostasGITolerability of modern antidepressantsJ Clin Psychiatry200869Suppl E181318494538
   PubMed Web of Science ®Google Scholar
• WiebeNVandermeerBPlattRWKlassenTPMoherDBarrowmanNJA systematic review identifies a lack of standardization in methods for handling missing variance dataJ Clin Epidemiol200659434235316549255
   PubMed Web of Science ®Google Scholar
• SterneJACEggerMMoherDBiasesARAddressing reporting biasesHigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011 The Cochrane Collaboration2011 Available from: http://www.cochrane-handbook.org
   Google Scholar
• JordanIRobertsonDCataniMCraigMMurphyDAripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorderPsychopharmacology2012223335736022535309
   PubMed Web of Science ®Google Scholar
• FindlingRLMankoskiRTimkoKA randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorderJ Clin Psychiatry2014751223024502859
   PubMed Web of Science ®Google Scholar
• MankoskiRStocktonGManosGAripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight changeJ Child Adolesc Psychopharmacol201323857257624138011
   PubMed Web of Science ®Google Scholar
• MiralSGencerOInal-EmirogluFNBaykaraBBaykaraADirikERisperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trialEur Child Adolesc Psychiatry20081711818080171
   PubMed Web of Science ®Google Scholar
• GencerOEmirogluFNMiralSBaykaraBBaykaraADirikEComparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance studyEur Child Adolesc Psychiatry200817421722518026891
   PubMed Web of Science ®Google Scholar
• ManeetonNManeetonBPutthisriSWoottilukPNarkpongphunASrisurapanontMRisperidone for children and adolescents with autism spectrum disorder: a systematic reviewNeuropsychiatr Dis Treat2018141811182030022830
   PubMed Web of Science ®Google Scholar
• De HertMDetrauxJvan WinkelRYuWCorrellCUMetabolic and cardiovascular adverse effects associated with antipsychotic drugsNat Rev Endocrinol20118211412622009159
   PubMed Web of Science ®Google Scholar
• ZhangJPGallegoJARobinsonDGMalhotraAKKaneJMCorrellCUEfficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysisInt J Neuropsychopharmacol20131661205121823199972
   PubMed Web of Science ®Google Scholar
• ShahAAAftabACoverdaleJQTc prolongation with antipsychotics: is routine ECG monitoring recommended?J Psychiatr Pract201420319620624847993
   PubMed Web of Science ®Google Scholar
• GhanizadehASahraeizadehABerkMA head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trialChild Psychiatry Hum Dev201445218519223801256
   PubMed Web of Science ®Google Scholar
• KentJMKushnerSNingXRisperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled studyJ Autism Dev Disord20134381773178323212807
   PubMed Web of Science ®Google Scholar